Pharmaceutical

City Therapeutics launches with $135m Series A funding

City Therapeutics has announced its launch accompanied by a $135m Series A financing to lead advancements in RNAi-based medicine.

Oct 10, 2024 - 04:00
City Therapeutics launches with $135m Series A funding
City Therapeutics has announced its launch accompanied by a $135m Series A financing to lead advancements in RNAi-based medicine.
Read the original article

Tags:

Previous Article

Clinical Dose Companies in Contract Manufacturing for the Pharmaceutical Industry

Next Article

Ipsen’s Elafibranor gains MHRA approval for PBC treatment

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Pharmalittle: Coherus undercuts AbbVie with discounted Humira; FDA approves second RSV vaccine

STAT+: Pharmalittle: Coherus undercuts AbbVie with disc...

Jun 2, 2023

STAT+: Here’s what you might have missed in Biden’s budget proposal

STAT+: Here’s what you might have missed in Biden’s bud...

Mar 13, 2024

Celiac study examines precisely how gluten triggers injury to intestine

Celiac study examines precisely how gluten triggers inj...

Jul 14, 2023